Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1618 to 1667 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 16 (syn16). [source:swissprot;acc:o14662]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 810\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 240.194\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 230.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 9.237\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 811\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 1a (neuron-specific antigen hpc-1). [source:swissprot;acc:q16623]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 812\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha-soluble nsf attachment protein (snap-alpha) (n-ethylmaleimide- sensitive factor attachment protein, alpha). [source:swissprot;acc:p54920]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 236.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.226\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 813\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adipocyte plasma membrane-associated protein (bscv protein). [source:swissprot;acc:q9hdc9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.599\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.2\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 814\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent synaptosomal-associated protein 29 (snap-29) (vesicle-membrane fusion protein snap-29) (soluble 29 kda nsf attachment protein). [source:swissprot;acc:o95721]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 244.155\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.195\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 815\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 4 (eif-3 delta) (eif3 p44) (eif-3 rna-binding subunit) (eif3 p42) (eif3g). [source:swissprot;acc:o75821]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 246.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.131\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 1b. [source:swissprot;acc:q15531]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 816\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 10 (eif-3 theta) (eif3 p167) (eif3 p180) (eif3 p185) (eif3a). [source:swissprot;acc:q14152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 246.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.131\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma antigen p15 (melanoma-associated antigen recognized by t lymphocytes). [source:swissprot;acc:q13084]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 221.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04425\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 817\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-binding protein rfxank (regulatory factor x subunit b) (rfx-b) (ankyrin repeat family a protein 1). [source:swissprot;acc:o14593]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent t-complex protein 1, gamma subunit (tcp-1-gamma) (cct-gamma). [source:swissprot;acc:p49368]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 110.689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 101.613\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.076\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 818\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 234.025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.958\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.067\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 168.592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 161.452\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04422\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 819\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.958\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.067\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase ii 14.5 kda polypeptide (ec 2.7.7.6) (rpb9) (rpb14.5). [source:swissprot;acc:p36954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04421\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 820\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s19. [source:swissprot;acc:p39019]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.958\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.067\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial 28s ribosomal protein s2 (mrp-s2) (cgi-91). [source:swissprot;acc:q9y399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.716\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04413\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 821\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l31. [source:swissprot;acc:p12947]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 234.025\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 224.958\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9.067\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent u3 snornp protein 4 homolog. [source:refseq;acc:nm\_033416]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.676\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0441\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 822\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 9 (eif-3 eta) (eif3 p116) (eif3 p110) (eif3b). [source:swissprot;acc:p55884]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 243.067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04408\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 55\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 9\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 823\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent transcription factor iib. [source:refseq;acc:nm\_013242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 197.471\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04354\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 824\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 8 (suppressor of white apricot protein homolog). [source:swissprot;acc:q12872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 197.471\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04354\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 825\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.674\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.985\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.214\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 197.614\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04352\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 826\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60 kda tat interactive protein (tip60) (hiv-1 tat interactive protein) (cpla(2) interacting protein). [source:swissprot;acc:q92993]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 223.186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.912\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04335\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerase ii 13.3 kda polypeptide (ec 2.7.7.6) (rpb11). [source:swissprot;acc:p52435]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 239.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.974\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 827\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent jm1 protein. [source:refseq;acc:nm\_014008]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 219.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 210.806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.956\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent loh1cr12. [source:refseq;acc:nm\_058169]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 220.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0431\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 828\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 135.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 144.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.954\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent unr protein. [source:swissprot;acc:o75534]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 230.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 220.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0431\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 829\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-repair protein complementing xp-g cells (xeroderma pigmentosum group g complementing protein) (dna excision repair protein ercc-5). [source:swissprot;acc:p28715]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 252.873\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 261.821\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.948\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent septin 4 (peanut-like protein 2) (brain protein h5) (cell division control-related protein 2) (hcdcrel-2) (bradeion beta) (ce5b3 beta) (cerebral protein-7) (hucep-7). [source:swissprot;acc:o43236]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 135.844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 130.259\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04288\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 830\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 231.734\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 222.222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0428\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent wd-repeat protein 3. [source:swissprot;acc:q9unx4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 243.896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.936\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 831\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.877\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 231.734\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 222.222\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0428\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 832\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thioredoxin domain-containing 2; sperm-specific thioredoxin; thioredoxin domain-containing 2 (spermatozoa). [source:refseq;acc:nm\_032243]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.877\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 833\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 231.734\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 222.222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0428\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent thioredoxin (atl-derived factor) (adf) (surface associated sulphydryl protein) (sasp). [source:swissprot;acc:p10599]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 238.048\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 8.877\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 231.734\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 222.222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0428\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/